Focusing the R&D direction in the field of Autoimmune Disease Diagnostic, MYBIOTECH has overcomed multiple key difficulties in the current diagnosis of neuroimmunological diseases in China. With developments of nearly a hundred In-Vitro diagnostic kits for multiple sclerosis, optic neuromyelitis, myasthenia gravis, peripheral neuropathy, autoimmune encephalitis, paraneoplastic syndrome and other series; 95% of the MYbiotech products are new in the domestic industry, with independent intellectual property rights.

R&D Achievement

The company is mainly engaged in the R&D and industrial development of auxiliary diagnostic kits for neuroimmune diseases and neuroinfectious diseases. The kits currently developed include: